Document
IPR2017-01100, No. 1009-8 Exhibit - Ex 1009 FDA Guideline on Sterile Drug Products Produced by Aseptic Processing June 1987, reprinted June 1991 and Feb 1997 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01100, No. 1009-8 Exhibit - Ex 1009 FDA Guideline on Sterile Drug Products Produced by Aseptic Processing June 1987, reprinted June 1991 and Feb 1997 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01100, No. 1017-16 Exhibit - Ex 1017 US Application No 11520,479, Non Final Office Action mailed Mar 30, 2010 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01100, No. 1017-16 Exhibit - Ex 1017 US Application No 11520,479, Non Final Office Action mailed Mar 30, 2010 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01100, No. 1012 Exhibit - Ex 1012 Elan Pharma Intl Ltd v Abraxis BioScience, Inc, Sixth Day of Trial, No 06 438 GMS, Dkt 624 D Del June 9, 2008 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01100, No. 1012 Exhibit - Ex 1012 Elan Pharma Intl Ltd v Abraxis BioScience, Inc, Sixth Day of Trial, No 06 438 GMS, Dkt 624 D Del June 9, 2008 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01100, No. 1025 Exhibit - Ex 1025 US Application No 11520,479, Notice of Allowance and Fees Due mailed Feb 13, 2014 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01100, No. 1025 Exhibit - Ex 1025 US Application No 11520,479, Notice of Allowance and Fees Due mailed Feb 13, 2014 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01100, No. 1010 Exhibit - Ex 1010 EMEA Guidance on Manufacture of the Finished Dosage Form April 1996 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01100, No. 1010 Exhibit - Ex 1010 EMEA Guidance on Manufacture of the Finished Dosage Form April 1996 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01100, No. 1007 Exhibit - Ex 1007 Klein et al, US Patent No 5,440,056 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01100, No. 1007 Exhibit - Ex 1007 Klein et al, US Patent No 5,440,056 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01100, No. 1024 Exhibit - Ex 1024 US Application No 11520,479, Supplemental Declaration of Neil P Desai Pursuant to 37 CFR 1132 dated Nov 1, 2013 2nd Inventor Declaration (P.T.A...
Cite Document
IPR2017-01100, No. 1024 Exhibit - Ex 1024 US Application No 11520,479, Supplemental Declaration of Neil P Desai Pursuant to 37 CFR 1132 dated Nov 1, 2013 2nd Inventor Declaration (P.T.A.B. Apr. 4, 2
+ More Snippets
Document
IPR2017-01100, No. 1021 Exhibit - Ex 1021 US Application No 11520,479, Declaration of Neil P Desai Pursuant to 37 CFR 1132 dated Jan 27, 2012 First Inventors Declaration (P.T.A.B. Apr. 4, 2...
Cite Document
IPR2017-01100, No. 1021 Exhibit - Ex 1021 US Application No 11520,479, Declaration of Neil P Desai Pursuant to 37 CFR 1132 dated Jan 27, 2012 First Inventors Declaration (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01100, No. 1032 Exhibit - Ex 1032 FDA Nanotechnology Task Force, Public Meeting on Nanotechnology Materials in FDA Regulated Products Oct 10, 2006 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01100, No. 1032 Exhibit - Ex 1032 FDA Nanotechnology Task Force, Public Meeting on Nanotechnology Materials in FDA Regulated Products Oct 10, 2006 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01100, No. 1002 Exhibit - Ex 1002 Declaration Of Cory J Berkland, PhD (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01100, No. 1002 Exhibit - Ex 1002 Declaration Of Cory J Berkland, PhD (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01100, No. 1011 Exhibit - Ex 1011 Elan Pharma Intl Ltd v Abraxis BioScience, Inc, Judgment and Verdict Form, No 06 438 GMS, Dkt 614 D Del June 16, 2008 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01100, No. 1011 Exhibit - Ex 1011 Elan Pharma Intl Ltd v Abraxis BioScience, Inc, Judgment and Verdict Form, No 06 438 GMS, Dkt 614 D Del June 16, 2008 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01100, No. 1003 Exhibit - Ex 1003 Desai et al, US Patent No 5,439,686 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01100, No. 1003 Exhibit - Ex 1003 Desai et al, US Patent No 5,439,686 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01100, No. 1009 Exhibit - Ex 1009 FDA Guideline on Sterile Drug Products Produced by Aseptic Processing June 1987, reprinted June 1991 and Feb 1997 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01100, No. 1009 Exhibit - Ex 1009 FDA Guideline on Sterile Drug Products Produced by Aseptic Processing June 1987, reprinted June 1991 and Feb 1997 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01100, No. 1023 Exhibit - Ex 1023 US Application No 11520,479, Amendment in Response to Non Final Office Action dated Nov 1, 2013 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01100, No. 1023 Exhibit - Ex 1023 US Application No 11520,479, Amendment in Response to Non Final Office Action dated Nov 1, 2013 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01100, No. 1019 Exhibit - Ex 1019 US Application No 11520,479, Final Office Action dated Dec 29, 2010 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01100, No. 1019 Exhibit - Ex 1019 US Application No 11520,479, Final Office Action dated Dec 29, 2010 (P.T.A.B. Apr. 4, 2017)
+ More Snippets